Fresenius Reaches Accord With FTC Over Anemia Drug
Fresenius Medical Care AG has settled a complaint with the Federal Trade Commission that will allow the company to acquire a license to sell the intravenous iron drug Venofer, but prevents...To view the full article, register now.
Already a subscriber? Click here to view full article